Recruiting A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871 Conditions Brain Diseases, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, +36 more Locations UCSD Moores Cancer Center — La Jolla, California, United States USC Norris Comprehensive Cancer Center — Los Angeles, California, United States University of Colorado Cancer Center — Aurora, Colorado, United States University of Miami — Miami, Florida, United States View all 53 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed PRS-343 in HER2-Positive Solid Tumors NCT03330561 Conditions HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more Locations University of Arizona Cancer Center — Tucson, Arizona, United States University of California Los Angeles (UCLA) — Santa Monica, California, United States Georgetown University, Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia, United States Johns Hopkins University School of Medicine — Baltimore, Maryland, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors NCT03650348 Conditions HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more Locations USC Norris Comprehensive Cancer Center — Los Angeles, California, United States Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States UCLA Health — Santa Monica, California, United States Ochsner Cancer Institute — New Orleans, Louisiana, United States View more locations Show fewer locations Loading locations... View Trial Details
